MPS Loria Financial Planners’s Biogen BIIB Stock Holding History

MPS Loria Financial Planners’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-15	Closed	-$4K	–	153
2021 Q1	$4K	Sell	15 -36	-71%	-$9.71K	﹤0.01%	355
2020 Q4	$12K	Buy	+51	New	+$13.2K	0.01%	280

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

MPS Loria Financial Planners's BIIB Position: Q2 2021 in Review

MPS Loria Financial Planners sold out of Biogen (BIIB) in Q2 2021, closing a stake of 15 shares — an estimated $4K sold.

MPS Loria Financial Planners first reported a position in BIIB in Q4 2020 and held it in 2 quarters. The position peaked at $12K in Q4 2020. 1,106 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.

MPS Loria Financial Planners reported no remaining Biogen position as of Q2 2021 after selling out during the quarter.
MPS Loria Financial Planners sold 15 Biogen shares in Q2 2021, an estimated $4K.
MPS Loria Financial Planners first reported a position in Biogen in Q4 2020 and held it in 2 quarters.
MPS Loria Financial Planners's Biogen position peaked at $12K in Q4 2020.
1,106 funds tracked by Wall St. Rank held Biogen as of Q2 2021.

Based on MPS Loria Financial Planners's 13F filing for Q2 2021, filed 20 Jul 2021.